| Code | 42281 | ||||||||||
| MA number | 56/0009/05-S | ||||||||||
| Product Form: | plv iol 1x7,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | pre-filled syringe | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 04.02.2005 |
| Pediatric contraindication: | Yes |
| Dokument: |
DHPC Leuprorelin - ELIGARD- 21 11 2014.pdf
|
| PIL: |
PIL_Eligard_7.5mg_08_2022.pdf
|
| SPC: |
SPC_Eligard_7.5mg_08_2022.pdf
|
| Safety feature | Yes |
| Data update: | 04.04.2019 |
